Evidence map›Paper›PMID 40198517›Full record

ArticleJournal of diabetes investigation2025

Case of type 1 diabetes mellitus with decreased hemoglobin glycation index after switching insulin pump.

Momoka Hasegawa, Akihiro Katayama, Eisaku Morimoto, Mayu Watanabe, Yuichi Matsushita, Masaya Takeda, Kazuyuki Hida

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of diabetes investigation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Momoka HasegawaDepartment of Diabetology and Endocrinology, NHO Okayama Medical Center, Okayama, Japan.
Akihiro KatayamaDepartment of Diabetology and Endocrinology, NHO Okayama Medical Center, Okayama, Japan.ORCID https://orcid.org/0000-0002-9729-7343
Eisaku MorimotoDepartment of Diabetology and Endocrinology, NHO Okayama Medical Center, Okayama, Japan.
Mayu WatanabeDepartment of Diabetology and Endocrinology, NHO Okayama Medical Center, Okayama, Japan.ORCID https://orcid.org/0000-0003-4253-3465
Yuichi MatsushitaDepartment of Diabetology and Endocrinology, NHO Okayama Medical Center, Okayama, Japan.
Masaya TakedaDepartment of Diabetology and Endocrinology, NHO Okayama Medical Center, Okayama, Japan.
Kazuyuki HidaDepartment of Diabetology and Endocrinology, NHO Okayama Medical Center, Okayama, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This case report described a 78-year-old woman with type 1 diabetes who experienced a significant decrease in the hemoglobin glycation index (HGI) after switching her insulin pump from MiniMed™770G to 780G. Despite minimal changes in glycemic control, including a slight decrease in the average sensor glucose and % coefficient of variation (%CV) from continuous glucose monitoring metrics, her glycated hemoglobin level decreased from 8.2% to 7.3%, and HGI decreased from approximately 1.3-0.5. Previous reports have shown that HGI indicates differences in the glycation rate of hemoglobin between individuals. Moreover, a high HGI is a risk factor for diabetic complications. However, there are no reports on changes in HGI within an individual. Therefore, the significance of intraindividual HGI changes, as in this case, should be investigated.

Indexed as

Diabetes Mellitus, Type 1Glycated HemoglobinHypoglycemic AgentsInsulinInsulin Infusion SystemsAgedBlood GlucoseFemaleHumansBlood GlucoseGlycated Hemoglobinhemoglobin A1c protein, humanHypoglycemic AgentsInsulinHemoglobin glycation indexInsulin pumpType 1 diabetes mellitus

Identifiers

PMID40198517
PMCPMC12209507

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.